Business Wire

WilsonHCG Recognized as a “Leader” in NelsonHall’s 2019 NEAT Vendor Evaluation for All RPO Categories

17.7.2019 15:00:00 EEST | Business Wire | Press release

Share

WilsonHCG has been identified as a “Leader” in NelsonHall’s NEAT Vendor Evaluation for RPO. The global talent solutions provider was recognized as a leader in all categories that were evaluated, including overall, candidate experience, geographic footprint & scalability, services delivery innovation, sourcing candidates and technology innovation.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190717005385/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

This chart shows WilsonHCG's position against other RPO providers for "Candidate Experience." Identified as a "Leader" in "Candidate Experience," this recognizes the company's ability to meet future client requirements as well as deliver immediate benefits to RPO clients with a specific focus on candidate experience. (Graphic: Business Wire)

Nikki Edwards, Principal HR Services Research Analyst at NelsonHall, said: “WilsonHCG’s proactive, innovative partnership approach is embedded in its culture. These strengths can be seen in its talent acquisition initiatives and are consistently highlighted as stand-out features by its clients.”

John Wilson, CEO at WilsonHCG, attributes being named a leader in all categories to its innovative approach. “This continual recognition is a result of the hard work and passion our people display every day. We are proud to rank as an overall RPO leader as well as our extremely strong showing related to candidate experience and service delivery innovation. We strive for excellence to help our clients exceed their talent and business goals,” he added.

NelsonHall's RPO NEAT Vendor Evaluation analyzes the performance of vendors offering RPO services. The NEAT tool allows strategic HR decision-makers to assess the capability of vendors across a range of criteria and business situations and identify the best performing vendors overall.

This recognition follows an exciting 12 months for WilsonHCG. The global talent solutions leader expanded into new markets and countries, was the only RPO provider to be named a “Star Performer” in Everest Group’s RPO Service Provider PEAK Matrix™ Assessment for the sixth year in a row and was recognized as a top global RPO provider in HRO Today Baker's Dozen for the eighth consecutive year.

Learn more here.

About WilsonHCG

WilsonHCG is an award-winning, global leader in total talent solutions. Operating as a strategic partner, it helps companies build modern workforce programs. With a global presence spanning more than 40 countries and six continents, WilsonHCG provides a full suite of configurable talent services including recruitment process outsourcing (RPO), executive search, contingent talent solutions, and technology advisory.

Better People, Better Business.®

www.wilsonhcg.com

About NelsonHall

NelsonHall is the leading global analyst firm dedicated to helping organizations understand the 'art of the possible' in IT and business services. NelsonHall provides buy-side organizations with detailed, critical information on markets and vendors (including NEAT assessments) that helps them make fast and highly informed sourcing decisions. And for vendors, NelsonHall provides deep knowledge of market dynamics and user requirements to help them hone their go-to-market strategies. NelsonHall’s research is based on rigorous, all-original research, and is widely respected for the quality, depth, and insight of its analysis.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Kirsty Hewitt
+44 7889901517
813-418-4479
kirsty.hewitt@wilsonhcg.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Thales Unveils a Global Framework to Protect Critical Organisations from Frontier AI Attacks1.10.2026 14:18:00 EEST | Press release

At the Thales Cyber Summit held in Paris (France) , Thales today unveiled a global response to the challenges created by Frontier AI models. Reasoning, autonomy and scale of these cutting-edge systems far exceed previous generations, and can accelerate vulnerability discovery, exploit development and cyberattack execution at machine speed. This marks a shift in AI from a tool that assists humans to one that acts autonomously, reshaping the threat landscape for organisations, the first of which those operating critical systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001459724/en/ ©Thales “Frontier AI models represent a new inflection point for cybersecurity. The challenge is not only technological; it is about helping organisations act before risks materialize, understand the implications, assess their exposure, and, if an attack still succeeds, ensure resilience and quick recovery. By combining advanced technologi

MidOcean Concludes 2026 Equity Raise, Securing More Than $4 Billion of Equity Commitments to Accelerate Global LNG Growth Strategy1.10.2026 14:00:00 EEST | Press release

MidOcean Energy ("MidOcean" or the "Company"), a liquefied natural gas (LNG) company formed and managed by EIG, today announced the conclusion of its 2026 equity capital raise, securing more than $4 billion of closed and pending commitments over the last 12 months from new strategic and institutional investors, as well as significant re-ups from existing investors. The capital committed significantly exceeded the Company's original target of $2 billion, reflecting continued confidence in MidOcean's strategy, portfolio, team and long-term growth outlook. The raise includes commitments from strategic investors, sovereign-linked institutions and financial investors. Among the new investors are the Private Department of Sheikh Mohammed bin Khalid Al Nahyan, Idemitsu Kosan, NYK Line (through Diamond Gas MidOcean), The Arab Energy Fund, Shizuoka Gas and certain Korean institutional investors. The proceeds are expected to enhance MidOcean's balance sheet flexibility and position the Company t

LISTERINE ® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion1.10.2026 13:45:00 EEST | Press release

Nearly half the world’s population is affected by oral disease – and the number of cases is rising. This World Smile Day, LISTERINE® is launching Oral Care Counts – a multiyear education and advocacy initiative showing why oral health is an essential part of overall health and how practical daily habits, including a three-step oral care routine of brushing, flossing and rinsing, can support better oral health.The multiyear education and advocacy campaign is designed to help more people understand the essential role oral health plays in overall health and wellbeing, and how realistic daily habits can make prevention more achievable. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001163338/en/ Oral Care Counts aims to bring together healthcare professionals, advocates, policymakers, community organizations, and consumers to raise understanding of oral health as an essential part of overall health and wellbeing. The initiati

Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates1.10.2026 11:30:00 EEST | Press release

Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the companies have entered into a global license, development, and commercialization agreement for up to six potential biosimilar candidates, with two confirmed investigational biosimilar candidates, SB41, a biosimilar candidate referencing Fasenra®1 (benralizumab), and SB44, a biosimilar candidate referencing Ilaris®2 (canakinumab). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001835078/en/ Under the terms of the agreement, Samsung Bioepis will be responsible for the development, regulatory registration, and manufacture of the biosimilars, while Teva will be responsible for commercialization in global markets, including the United States (U.S.), Europe, and Canada. The companies have agreed to an option for expanding the partnership to other territories. This agreement reinforces the long-standing and successful

FPT and ZEBOX Partner to Advance AI and Sustainable Innovation in Logistics1.10.2026 11:00:00 EEST | Press release

FPT, a global technology and IT services provider, and ZEBOX, the international innovation accelerator initiated by the CMA CGM Group, have entered into a three-year strategic partnership to develop and deploy AI-powered solutions for the transport and logistics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261001622214/en/ The partnership was formalized during the Vietnam - France Leaders Forum, held as part of Vietnam’s General Secretary and State President’s official visit to France. The partnership will combine FPT’s expertise in artificial intelligence, automation and large-scale digital transformation with ZEBOX’s innovation network and its close connection to the CMA CGM Group’s global transport and logistics ecosystem. The partners will focus on shipping, port operations, logistics, supply chain management and clean energy. A first joint initiative in Vietnam As a first step, FPT, ZEBOX and CMA CGM Vietnam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye